Business · 13/06/2008
FDA Approves Deracoxib for Pain and Inflammation in Dogs
The FDA is amending its animal drug regulations to reflect the approval of a supplemental new animal drug application (NADA) for a 50-milligram deracoxib tablet, a pain and inflammation treatment for dogs, filed by Novartis Animal Health US, Inc.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →